Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials

SIMPLE SUMMARY: There is a crucial need to improve treatment regimens in patients with recurrent endometrial cancer. Although immunotherapy treatments have shown impressive benefit in microsatellite instability-high endometrial cancer, they have been less predictable in the majority of endometrial c...

Descripción completa

Detalles Bibliográficos
Autores principales: How, Jeffrey A., Jazaeri, Amir A., Fu, Siqing, Rodon Ahnert, Jordi, Gong, Jing, Stephen, Bettzy, Ferreira Dalla Pria, Hanna, Bhosale, Priya, Johnson, Amber, Yuan, Ying, Meric-Bernstam, Funda, Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367373/
https://www.ncbi.nlm.nih.gov/pubmed/35954359
http://dx.doi.org/10.3390/cancers14153695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367373/
https://www.ncbi.nlm.nih.gov/pubmed/35954359
http://dx.doi.org/10.3390/cancers14153695

Ejemplares similares